Menu
Wed, 28 February 2024

Newsletter sign-up

Subscribe now
The House Live All
Why system change is critical to harness the potential of gene therapies Partner content
By Pfizer UK
Health
Major new report reveals pathways to better neurological care Partner content
By Roche Products Ltd
Health
Culture shift: tackling antimicrobial resistance from agriculture to operating table Partner content
Health
Taking learnings from the pandemic to improve global trade rules for health Partner content
By MSD
Health
Stronger foundations: transforming neurological care Partner content
By Roche Products Ltd
Health
Press releases

Government promises to protect NHS in US trade talks

2 min read

International trade minister Greg Hands has promised to protect the NHS from US attempts to force the service to pay more for prescription drugs. 


NHS England, which already spends £16 billion per year on prescription drugs, could be forced to pay higher prices by the US government under the terms of any future trade deal. 

Speaking to The Times, Mr Hands said that the NHS would be protected in any future trade agreement with the US. 

‘I think the most important thing to understand, with all trade agreements, is that no trade agreement prevents a country from having the domestic right to regulate’ he said. 

‘We have always been clear that, in all trade agreements, the NHS will be protected.’ 

Accusing other countries of ‘freeloading’, US Health and Human Services Secretary Alex Azar told CNBC that the government would force foreign health services to pay higher prices for prescription drugs. 

‘The reason why they are getting better net prices than we get is their socialised system’ he said. 

‘On the foreign side we need to, through our trade negotiations and agreements, pressure them.’

‘And so we pay less, they pay more. It shouldn’t be a one-way ratchet. We all have some skin in this game.’ 

David Henig, who worked on the Transatlantic Trade and Investment Partnership (TTIP) as assistant director of the Department for International Trade, said that the NHS could face sustained pressure from the US pharmaceutical lobby during trade negotiations. 

‘The threat of higher drug prices is a real threat to the National Health Service is a real threat because the American pharmaceutical companies have always felt threatened by its power and influence in setting drug prices’ Mr Henig told The Times.

‘Rather than telling us blandly that the NHS is safe from trade agreements the government needs to engage with stakeholders on the detail of what should and should not be in trade agreements.’

PoliticsHome Newsletters

PoliticsHome provides the most comprehensive coverage of UK politics anywhere on the web, offering high quality original reporting and analysis: Subscribe

Read the most recent article written by Alex Hacillo - Philip Hammond 'forced to abandon' private school VAT plans

Categories

Health